Our primary conclusion from the conference is that the underlying fundamentals continue to be solid, especially on the demand side, and that the more challenging supply side is further improving (labour).
However, macroeconomic conditions, political factors, and sentiment could introduce additional volatility, and we anticipate that the dispersion of returns among stocks will be high for the next couple of quarters.
Find out more in the link below!
Should you want to know more about our conclusions, please contact us!— Raphael Oesch, Portfolio Manager
What mattered this month in healthcare? The readout of the SELECT study was the single biggest healthcare event of the month. The results may open the door to wide reimbursement for GLP-1 weight-loss drugs. This led to an overreaction with significant price movements amongst many companies as markets just made blanket assumptions of a healthier, thinner world. Find out more in our monthly healthcare newsletter.
Remarkable Strides in Breast Cancer Survival: A Look at the Last Few Decades 🎗️📈 Intersted in knowing more? Check out Maria Specogna’s latest chart of the month video!
What mattered this month in healthcare? Second quarter earnings season kicked off to a strong start, with earnings overall better than estimates. However, positioning matters, and strong numbers were not always enough if expectations were high. Find out more in our monthly healthcare newsletter.